Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation

Dong Yun Zhan, Cheng Kun Du, Tsuyoshi Akiyama, Sachio Morimoto, Shuji Shimizu, Toru Kawada, Mikiyasu Shirai, James T. Pearson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The aim of this study was to evaluate cardiac vagal nerve activity and identify the abnormality of cardiac vagal control in heart failure caused by dilated cardiomyopathy (DCM) using a knock-in mouse model with a ΔK210 mutation in the cardiac troponin T gene. The effects of electrical stimulation of the cervical vagal nerve at 5 and 10 Hz (peripheral vagal control) and α2-adrennoceptor stimulation by intravenous medetomidine at 0.1 mg/kg (central vagal control) were examined in wild-type (WT) mice and DCM mice. Microdialysis technique was applied to the left ventricular myocardium of anesthetized mice and myocardial interstitial acetylcholine (ACh) levels were measured by HPLC as an index of ACh release from cardiac vagal nerve endings. Electrical vagal nerve stimulation increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, and these responses did not differ between WT and DCM mice. In contrast, intravenous medetomidine increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, but the responses of cardiac interval and myocardial interstitial ACh level were significantly suppressed in DCM mice compared to WT mice. Medetomidine did not affect the myocardial interstitial ACh response induced by vagal nerve stimulation in WT mice. In this mouse model of DCM, peripheral vagal control including ACh release from vagal nerve endings and the postsynaptic response of pacemaker cells was preserved, but central vagal control through α2-adrenoceptors was impaired.

Original languageEnglish
Pages (from-to)33-40
Number of pages8
JournalAutonomic Neuroscience: Basic and Clinical
Volume205
DOIs
Publication statusPublished - Jul 2017

Fingerprint

Troponin
Dilated Cardiomyopathy
Mutation
Acetylcholine
Medetomidine
Vagus Nerve Stimulation
Nerve Endings
Troponin T
Microdialysis
Adrenergic Receptors
Electric Stimulation
Myocardium
Heart Failure
High Pressure Liquid Chromatography

All Science Journal Classification (ASJC) codes

  • Endocrine and Autonomic Systems
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation. / Zhan, Dong Yun; Du, Cheng Kun; Akiyama, Tsuyoshi; Morimoto, Sachio; Shimizu, Shuji; Kawada, Toru; Shirai, Mikiyasu; Pearson, James T.

In: Autonomic Neuroscience: Basic and Clinical, Vol. 205, 07.2017, p. 33-40.

Research output: Contribution to journalArticle

Zhan, DY, Du, CK, Akiyama, T, Morimoto, S, Shimizu, S, Kawada, T, Shirai, M & Pearson, JT 2017, 'Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation', Autonomic Neuroscience: Basic and Clinical, vol. 205, pp. 33-40. https://doi.org/10.1016/j.autneu.2017.03.002
Zhan, Dong Yun ; Du, Cheng Kun ; Akiyama, Tsuyoshi ; Morimoto, Sachio ; Shimizu, Shuji ; Kawada, Toru ; Shirai, Mikiyasu ; Pearson, James T. / Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation. In: Autonomic Neuroscience: Basic and Clinical. 2017 ; Vol. 205. pp. 33-40.
@article{b10ba21fca6745ccae7b09ade9e9cb28,
title = "Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation",
abstract = "The aim of this study was to evaluate cardiac vagal nerve activity and identify the abnormality of cardiac vagal control in heart failure caused by dilated cardiomyopathy (DCM) using a knock-in mouse model with a ΔK210 mutation in the cardiac troponin T gene. The effects of electrical stimulation of the cervical vagal nerve at 5 and 10 Hz (peripheral vagal control) and α2-adrennoceptor stimulation by intravenous medetomidine at 0.1 mg/kg (central vagal control) were examined in wild-type (WT) mice and DCM mice. Microdialysis technique was applied to the left ventricular myocardium of anesthetized mice and myocardial interstitial acetylcholine (ACh) levels were measured by HPLC as an index of ACh release from cardiac vagal nerve endings. Electrical vagal nerve stimulation increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, and these responses did not differ between WT and DCM mice. In contrast, intravenous medetomidine increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, but the responses of cardiac interval and myocardial interstitial ACh level were significantly suppressed in DCM mice compared to WT mice. Medetomidine did not affect the myocardial interstitial ACh response induced by vagal nerve stimulation in WT mice. In this mouse model of DCM, peripheral vagal control including ACh release from vagal nerve endings and the postsynaptic response of pacemaker cells was preserved, but central vagal control through α2-adrenoceptors was impaired.",
author = "Zhan, {Dong Yun} and Du, {Cheng Kun} and Tsuyoshi Akiyama and Sachio Morimoto and Shuji Shimizu and Toru Kawada and Mikiyasu Shirai and Pearson, {James T.}",
year = "2017",
month = "7",
doi = "10.1016/j.autneu.2017.03.002",
language = "English",
volume = "205",
pages = "33--40",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cardiac vagal control in a knock-in mouse model of dilated cardiomyopathy with a troponin mutation

AU - Zhan, Dong Yun

AU - Du, Cheng Kun

AU - Akiyama, Tsuyoshi

AU - Morimoto, Sachio

AU - Shimizu, Shuji

AU - Kawada, Toru

AU - Shirai, Mikiyasu

AU - Pearson, James T.

PY - 2017/7

Y1 - 2017/7

N2 - The aim of this study was to evaluate cardiac vagal nerve activity and identify the abnormality of cardiac vagal control in heart failure caused by dilated cardiomyopathy (DCM) using a knock-in mouse model with a ΔK210 mutation in the cardiac troponin T gene. The effects of electrical stimulation of the cervical vagal nerve at 5 and 10 Hz (peripheral vagal control) and α2-adrennoceptor stimulation by intravenous medetomidine at 0.1 mg/kg (central vagal control) were examined in wild-type (WT) mice and DCM mice. Microdialysis technique was applied to the left ventricular myocardium of anesthetized mice and myocardial interstitial acetylcholine (ACh) levels were measured by HPLC as an index of ACh release from cardiac vagal nerve endings. Electrical vagal nerve stimulation increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, and these responses did not differ between WT and DCM mice. In contrast, intravenous medetomidine increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, but the responses of cardiac interval and myocardial interstitial ACh level were significantly suppressed in DCM mice compared to WT mice. Medetomidine did not affect the myocardial interstitial ACh response induced by vagal nerve stimulation in WT mice. In this mouse model of DCM, peripheral vagal control including ACh release from vagal nerve endings and the postsynaptic response of pacemaker cells was preserved, but central vagal control through α2-adrenoceptors was impaired.

AB - The aim of this study was to evaluate cardiac vagal nerve activity and identify the abnormality of cardiac vagal control in heart failure caused by dilated cardiomyopathy (DCM) using a knock-in mouse model with a ΔK210 mutation in the cardiac troponin T gene. The effects of electrical stimulation of the cervical vagal nerve at 5 and 10 Hz (peripheral vagal control) and α2-adrennoceptor stimulation by intravenous medetomidine at 0.1 mg/kg (central vagal control) were examined in wild-type (WT) mice and DCM mice. Microdialysis technique was applied to the left ventricular myocardium of anesthetized mice and myocardial interstitial acetylcholine (ACh) levels were measured by HPLC as an index of ACh release from cardiac vagal nerve endings. Electrical vagal nerve stimulation increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, and these responses did not differ between WT and DCM mice. In contrast, intravenous medetomidine increased cardiac interval and myocardial interstitial ACh level in both WT and DCM mice, but the responses of cardiac interval and myocardial interstitial ACh level were significantly suppressed in DCM mice compared to WT mice. Medetomidine did not affect the myocardial interstitial ACh response induced by vagal nerve stimulation in WT mice. In this mouse model of DCM, peripheral vagal control including ACh release from vagal nerve endings and the postsynaptic response of pacemaker cells was preserved, but central vagal control through α2-adrenoceptors was impaired.

UR - http://www.scopus.com/inward/record.url?scp=85016010481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016010481&partnerID=8YFLogxK

U2 - 10.1016/j.autneu.2017.03.002

DO - 10.1016/j.autneu.2017.03.002

M3 - Article

C2 - 28344023

AN - SCOPUS:85016010481

VL - 205

SP - 33

EP - 40

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

ER -